These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 9138434

  • 1. The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
    Sumiyoshi T, Ichikawa J, Meltzer HY.
    Neuropsychopharmacology; 1997 Mar; 16(3):183-90. PubMed ID: 9138434
    [Abstract] [Full Text] [Related]

  • 2. 5-HT1A and 5-HT2A receptor mRNAs and binding site densities are differentially altered in schizophrenia.
    Burnet PW, Eastwood SL, Harrison PJ.
    Neuropsychopharmacology; 1996 Nov; 15(5):442-55. PubMed ID: 8914117
    [Abstract] [Full Text] [Related]

  • 3. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
    Schreiber R, Brocco M, Audinot V, Gobert A, Veiga S, Millan MJ.
    J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
    [Abstract] [Full Text] [Related]

  • 4. Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
    Metwally KA, Dukat M, Egan CT, Smith C, DuPre A, Gauthier CB, Herrick-Davis K, Teitler M, Glennon RA.
    J Med Chem; 1998 Dec 03; 41(25):5084-93. PubMed ID: 9836624
    [Abstract] [Full Text] [Related]

  • 5. [Effects of serotonergic drugs on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum].
    Ishikane T.
    Hokkaido Igaku Zasshi; 1998 Sep 03; 73(5):441-9. PubMed ID: 9846274
    [Abstract] [Full Text] [Related]

  • 6. Effects of serotonergic agents on the up-regulation of dopamine D2 receptors induced by haloperidol in rat striatum.
    Ishikane T, Kusumi I, Matsubara R, Matsubara S, Koyama T.
    Eur J Pharmacol; 1997 Feb 26; 321(2):163-9. PubMed ID: 9063684
    [Abstract] [Full Text] [Related]

  • 7. Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors.
    Scandroglio A, Monferini E, Borsini F.
    Pharmacol Res; 2001 Feb 26; 43(2):179-83. PubMed ID: 11243720
    [Abstract] [Full Text] [Related]

  • 8. Regional changes in 5-HT1A but not in 5-HT2A receptors in mouse brain after Semliki Forest virus infection: radioligand binding and autoradiographic studies.
    Mehta S, Kitchen I.
    J Neurovirol; 1998 Dec 26; 4(6):606-18. PubMed ID: 10065902
    [Abstract] [Full Text] [Related]

  • 9. F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.
    Bruins Slot LA, Lestienne F, Grevoz-Barret C, Newman-Tancredi A, Cussac D.
    Eur J Pharmacol; 2009 Oct 12; 620(1-3):27-35. PubMed ID: 19695244
    [Abstract] [Full Text] [Related]

  • 10. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain.
    Tilakaratne N, Friedman E.
    Eur J Pharmacol; 1996 Jun 27; 307(2):211-7. PubMed ID: 8832223
    [Abstract] [Full Text] [Related]

  • 11. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
    Naidu PS, Kulkarni SK.
    Eur J Pharmacol; 2001 Sep 28; 428(1):81-6. PubMed ID: 11779040
    [Abstract] [Full Text] [Related]

  • 12. Effects of maternal ethanol consumption and buspirone treatment on 5-HT1A and 5-HT2A receptors in offspring.
    Kim JA, Gillespie RA, Druse MJ.
    Alcohol Clin Exp Res; 1997 Oct 28; 21(7):1169-78. PubMed ID: 9347075
    [Abstract] [Full Text] [Related]

  • 13. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
    Gogos A, Kwek P, Chavez C, van den Buuse M.
    J Pharmacol Exp Ther; 2010 Apr 28; 333(1):218-27. PubMed ID: 20042529
    [Abstract] [Full Text] [Related]

  • 14. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C, Carilla-Durand E, Assié MB, Ormiere AM, Maraval M, Leduc N, Newman-Tancredi A.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):135-44. PubMed ID: 16554049
    [Abstract] [Full Text] [Related]

  • 15. Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.
    Huang M, Panos JJ, Kwon S, Oyamada Y, Rajagopal L, Meltzer HY.
    J Neurochem; 2014 Mar 27; 128(6):938-49. PubMed ID: 24164459
    [Abstract] [Full Text] [Related]

  • 16. 1,4-Benzoxazin-3(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands; the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity.
    Mokrosz MJ, Kowalski P, Kowalska T, Majka Z, Duszyńska B, Charakchieva-Minol S, Szaro A, Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E.
    Pol J Pharmacol; 1998 Mar 27; 50(4-5):333-40. PubMed ID: 10091718
    [Abstract] [Full Text] [Related]

  • 17. Serotonin 5-HT1A, 5-HT2A and dopamine D2 receptors strongly influence prefronto-hippocampal neural networks in alert mice: Contribution to the actions of risperidone.
    Gener T, Tauste Campo A, Alemany-González M, Nebot P, Delgado-Sallent C, Chanovas J, Puig MV.
    Neuropharmacology; 2019 Nov 01; 158():107743. PubMed ID: 31430459
    [Abstract] [Full Text] [Related]

  • 18. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: I. Interaction with cloned human (h)5-HT1A, dopamine hD2/hD3 and h alpha2A-adrenergic receptors in relation to modulation of cortical monoamine release and activity in models of potential antidepressant activity.
    Millan MJ, Newman-Tancredi A, Rivet JM, Brocco M, Lacroix P, Audinot V, Cistarelli L, Gobert A.
    J Pharmacol Exp Ther; 1997 Jul 01; 282(1):132-47. PubMed ID: 9223549
    [Abstract] [Full Text] [Related]

  • 19. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I, Ogren SO.
    Neuropsychopharmacology; 2000 Feb 01; 22(2):168-90. PubMed ID: 10649830
    [Abstract] [Full Text] [Related]

  • 20. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H.
    J Pharmacol Exp Ther; 1994 Mar 01; 268(3):1432-43. PubMed ID: 8138956
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.